RIBAVIRIN THERAPEUTIC DRUG MONITORING IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HEPATITIS C

被引：0
|
作者：
Roberts, D. [1 ]
Ray, J. [1 ]
Furlong, T. [1 ]
机构：
[1] St Vincents Hosp, Sydney, NSW, Australia
来源：
NEPHROLOGY | 2010年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
190
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] The Utility of Therapeutic Drug Monitoring for Ribavirin in Patients with Chronic Hepatitis C-A Critical Review
    Chan, Alice H. W.
    Partovi, Nilufar
    Ensom, Mary H. H.
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (12) : 2044 - 2063
  • [2] Feasibility of Ribavirin Therapeutic Drug Monitoring in Hepatitis C
    Sauvage, Francois-Ludovic
    Stanke-Labesque, Francoise
    Gagnieu, Marie-Claude
    Jourdil, Jean-Francois
    Babany, Gerard
    Marquet, Pierre
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (03) : 374 - 381
  • [3] Therapeutic Drug Monitoring of Vancomycin in Chronic Kidney Disease Patients
    Salih, Muhannad R. M.
    Hassan, Yahaya
    [J]. HEALTHMED, 2010, 4 (02): : 379 - 385
  • [4] Optimizing Ribavirin Exposure by Therapeutic Drug Monitoring Improves Treatment Response in Patients With Chronic Hepatitis C Genotype 1
    Stickel, Felix
    Worni, Mathias
    Pache, Isabelle
    Moradpour, Darius
    Helbling, Beat
    Borovicka, Jan
    Gerlach, Tilman J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (07): : 1176 - 1178
  • [5] Serum ribavirin quantification for therapeutic drug monitoring during chronic hepatitis C combination treatment.
    Larrat, S
    Stanke, F
    Plages, A
    Zarski, JP
    Bessard, G
    Souvignet, C
    [J]. HEPATOLOGY, 2002, 36 (04) : 293A - 293A
  • [6] Kidney disease in patients with chronic hepatitis c
    Philipneri M.
    Bastani B.
    [J]. Current Gastroenterology Reports, 2001, 3 (1) : 79 - 83
  • [7] Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease
    Khoei, Ahmad
    Soltani, Rasool
    Emami, Jaber
    Badri, Shirinsadat
    Taheri, Shahram
    [J]. RESEARCH IN PHARMACEUTICAL SCIENCES, 2019, 14 (01) : 84 - 92
  • [8] Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease
    Anez-Castano, Rebeca
    Iniesta-Navalon, Carles
    Almanchel-Rivadeneyra, Miguel
    Garcia-Villalba, Eva
    Oliver-Galera, Eva
    Rentero-Redondo, Lorena
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [9] Hepatitis C infection in patients with chronic kidney disease
    Mangia, A.
    Burra, P.
    Ciancio, A.
    Fagiuoli, S.
    Guido, M.
    Picciotto, A.
    Fabrizi, F.
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2008, 31 (01): : 15 - 33
  • [10] Management of hepatitis C in patients with chronic kidney disease
    Carvalho-Filho, Roberto J.
    Feldner, Ana Cristina C. A.
    Silva, Antonio Eduardo B.
    Ferraz, Maria Lucia G.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (02) : 408 - 422
12345